Cargando…
Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report
BACKGROUND: Hepatic encephalopathy is a serious complication of cirrhosis that presents with a variety of neuropsychiatric abnormalities, including disorientation, asterixis, and coma. Seizures are an uncommon and potentially dangerous complication of hepatic encephalopathy. We present a unique case...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560308/ https://www.ncbi.nlm.nih.gov/pubmed/31210820 http://dx.doi.org/10.3889/oamjms.2019.458 |
_version_ | 1783425945326059520 |
---|---|
author | Chowdhury, Aneesa R. Marcus, Erin N. |
author_facet | Chowdhury, Aneesa R. Marcus, Erin N. |
author_sort | Chowdhury, Aneesa R. |
collection | PubMed |
description | BACKGROUND: Hepatic encephalopathy is a serious complication of cirrhosis that presents with a variety of neuropsychiatric abnormalities, including disorientation, asterixis, and coma. Seizures are an uncommon and potentially dangerous complication of hepatic encephalopathy. We present a unique case of a 42-year-old female with a history of well-controlled seizure disorder suddenly become refractory to anticonvulsant therapy following the development of hepatic encephalopathy secondary to liver decompensation. CASE PRESENTATION: A 42-year-old female presented to our hospital following a seizure accompanied by loss of consciousness, urinary incontinence, and the prolonged postictal state. She reports her seizures were initially well-controlled with Levetiracetam 500 mg twice a day but recently began experiencing seizures every other day despite up-titration of Levetiracetam to 1500 mg twice a day over a few weeks. On arrival, her serum ammonia level was 116 μmol/L. CT brain was negative while CT liver was consistent with cirrhotic morphology. An electroencephalogram revealed irregular, diffuse, delta/theta slowing consistent with mild to moderate encephalopathy. The patient was started on lactulose 40mg and Rifaximin 550 mg twice a day. Her symptoms of disorientation and lethargy resolved over 3 days. CONCLUSION: Though uncommon, hepatic encephalopathy should be considered in patients presenting with convulsions, especially if there is a known history of liver disease. Until the underlying liver issues are addressed, patients may not respond to traditional anti-convulsant therapy for their seizures. |
format | Online Article Text |
id | pubmed-6560308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Republic of Macedonia |
record_format | MEDLINE/PubMed |
spelling | pubmed-65603082019-06-17 Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report Chowdhury, Aneesa R. Marcus, Erin N. Open Access Maced J Med Sci Case Report BACKGROUND: Hepatic encephalopathy is a serious complication of cirrhosis that presents with a variety of neuropsychiatric abnormalities, including disorientation, asterixis, and coma. Seizures are an uncommon and potentially dangerous complication of hepatic encephalopathy. We present a unique case of a 42-year-old female with a history of well-controlled seizure disorder suddenly become refractory to anticonvulsant therapy following the development of hepatic encephalopathy secondary to liver decompensation. CASE PRESENTATION: A 42-year-old female presented to our hospital following a seizure accompanied by loss of consciousness, urinary incontinence, and the prolonged postictal state. She reports her seizures were initially well-controlled with Levetiracetam 500 mg twice a day but recently began experiencing seizures every other day despite up-titration of Levetiracetam to 1500 mg twice a day over a few weeks. On arrival, her serum ammonia level was 116 μmol/L. CT brain was negative while CT liver was consistent with cirrhotic morphology. An electroencephalogram revealed irregular, diffuse, delta/theta slowing consistent with mild to moderate encephalopathy. The patient was started on lactulose 40mg and Rifaximin 550 mg twice a day. Her symptoms of disorientation and lethargy resolved over 3 days. CONCLUSION: Though uncommon, hepatic encephalopathy should be considered in patients presenting with convulsions, especially if there is a known history of liver disease. Until the underlying liver issues are addressed, patients may not respond to traditional anti-convulsant therapy for their seizures. Republic of Macedonia 2019-05-30 /pmc/articles/PMC6560308/ /pubmed/31210820 http://dx.doi.org/10.3889/oamjms.2019.458 Text en Copyright: © 2019 Aneesa R. Chowdhury, Erin N. Marcus. http://creativecommons.org/licenses/CC BY-NC/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). |
spellingShingle | Case Report Chowdhury, Aneesa R. Marcus, Erin N. Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report |
title | Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report |
title_full | Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report |
title_fullStr | Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report |
title_full_unstemmed | Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report |
title_short | Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report |
title_sort | seizure disorder exacerbated by hepatic encephalopathy: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560308/ https://www.ncbi.nlm.nih.gov/pubmed/31210820 http://dx.doi.org/10.3889/oamjms.2019.458 |
work_keys_str_mv | AT chowdhuryaneesar seizuredisorderexacerbatedbyhepaticencephalopathyacasereport AT marcuserinn seizuredisorderexacerbatedbyhepaticencephalopathyacasereport |